| UHC Surest Medical and Drug | Walkers - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Whole Exome and Whole Genome Sequencing (Non-Oncology Conditions) - Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Xiaflex® (Collagenase Clostridium Histolyticum) - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Oxford Medical and Drug | In-Office Laboratory Testing and Procedures List - Oxford Administrative Policy | 2026-01-01 |
| Wellcare North Carolina Medicaid Clinical | Acute Inpatient Hospital Services | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Preferred Agents and Drug List (09-J90)00-01 | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Abatacept (Orencia®) Injection and Infusion (09-J0000-67) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Abrocitinib (Cibinqo®) Tablets (09-J4000-27) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Anakinra (Kineret®) Injection (09-J0000-45) | 2026-01-01 |
| BCBS Florida Coverage Guidelines | Apremilast (Otezla, Otezla XR) Tablet (09-J2000-19) | 2026-01-01 |